FDA Advisory approves Lilly's CYRAMZA (ramucirumab) for type of lung Cancer Medical Dialogues Bureau1 March 2020 2:00 PM ISTThe ODAC considered the safety and efficacy data from the Phase 3 RELAY trial, which is the basis for the CYRAMZA supplemental Biologics License...
Biohaven Receives Fda Approval for acute migraine drug Medical Dialogues Bureau1 March 2020 12:30 PM ISTA single quick-dissolving tablet of NURTEC ODT can provide fast pain relief and return patients to normal function within one hour, and deliver...
Merck, AMCM collaborates for 3D Printing of Tablets Medical Dialogues Bureau1 March 2020 10:30 AM IST3D printing allows for API (active pharmaceutical development) formulation to be scalable while avoiding costly reformulations throughout the entire...
Sandoz commits to keep prices of essential medicines stable amidst coronavirus fear Medical Dialogues Bureau1 March 2020 10:00 AM ISTGermany: Sandoz the provider of off-patent antibiotic medicines worldwide, made a public commitment to ensure stable pricing for a basket of essential...
Tramadol supplied globally from India as psychotropic substance: UN body Medical Dialogues Bureau29 Feb 2020 2:54 PM ISTGlobally, most of the tramadol, which is not an internationally controlled substance, that was seized from 2013 to 2017 was reported to have...
Dr Reddy's Laboratories launches generic of Naproxen, Esomeprazole Magnesium Delayed-Release Tablets Medical Dialogues Bureau29 Feb 2020 1:30 PM ISTDr Reddy's Naproxen and Esomeprazole Magnesium Delayed-Release Tablets are available in 375 mg/20 mg and 500 mg/20 mg tablets in bottle count sizes of...
Biocon Small Molecules API Manufacturing Facility Completes Post -Approval and GMP USFDA Inspection Medical Dialogues Bureau29 Feb 2020 11:35 AM ISTNew Delhi: Drug API maker, Biocon has informed that the U.S. Food and Drug Administration (FDA) conducted a Post-Approval and GMP inspection of Small...
Spanish Pharmaceutical Leader Ferrer Partners with Wellthy Therapeutics Medical Dialogues Bureau29 Feb 2020 10:45 AM ISTNew Delhi: Wellthy Therapeutics DTx solution has emerged global winner at Ferrer's 4 Future Innovation Challenge The Ferrer 4 Future...
Mylan warns of possible drug shortages, financial hit due to coronavirus Medical Dialogues Bureau29 Feb 2020 9:30 AM ISTAlthough heavily reliant on China, the company said it was better positioned against the impact of the outbreak compared to its peers due to its...
Covid-19 Impact: NPPA asks drugmakers to submit availablility data of 58 APIs, details Medical Dialogues Bureau28 Feb 2020 4:26 PM ISTNew Delhi: In the light of coronavirus outbreak worldwide, the apex drug regulator National Pharmaceutical Pricing Authority (NPPA) has identified 58...
Glenmark Pharmaceuticals ,Hikma enter join hands for commercializing Ryaltris™ Seasonal Allergic Rhinitis Nasal Spray in US Medical Dialogues Bureau28 Feb 2020 2:42 PM ISTRyaltris™ [olopatadine hydrochloride (665 mcg) and mometasone furoate (25 mcg)], developed by Glenmark, is a novel fixed-dose combination nasal spray...
Sanjeev Narula CFO Pfizer Upjohn appointed as incoming CFO of Viatris Medical Dialogues Bureau28 Feb 2020 1:45 PM ISTViatris is the new company that will result from the planned combination of Mylan and Upjohn
